Nevertheless, the levels of IL-1β, IL-6, and TNF-α secreted by mature DC of MS patients are significantly higher as compared to those from healthy controls, even following treatment with 1,25(OH)2D3. This evidence concerns the gene IL1B and myeloid sarcoma.